IVF INVO Fertility, Inc.
Healthcare$1.64+3.80%ClosedMarket Cap: $2.3M
As of 2026-05-25
Valuation
View DetailsP/E (TTM)
—
PEG
—
P/B
0.40
P/S
0.33
EV/EBITDA
-0.74
DCF Value
$-10,511.80
FCF Yield
-340.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
31.4%
Operating Margin
-139.2%
Net Margin
-394.9%
ROE
-446.6%
ROA
-145.6%
ROIC
-88.6%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 null | $1.8M | $-2.6M | $— |
| Q2 null | $1.9M | $-3.8M | $— |
| Q1 null | $1.6M | $-17.4M | $— |
| Q4 null | $1.7M | $-3.6M | $— |
Analyst Ratings
View AllConsensus
Buy
Target (Consensus)
$20.00
Target (Median)
$20.00
Target Range
$20.00 - $20.00
1 Strong Buy0 Buy0 Hold0 Sell0 Strong Sell
Trading Activity
Insider Trades
View AllKrigsvold Terah Reneeofficer: Chief Financial Officer
SellTue Jan 13
Krigsvold Terah Reneeofficer: Chief Financial Officer
SellTue Jan 13
Krigsvold Terah Reneeofficer: Chief Financial Officer
SellTue Jan 13
Krigsvold Terah Reneeofficer: Chief Financial Officer
SellTue Jan 13
Krigsvold Terah Reneeofficer: Chief Financial Officer
SellTue Jan 13
Company Info
Sector
Healthcare
Industry
Medical - Devices
Country
US
Exchange
—
Beta
2.32
INVO Fertility, Inc. operates as a revenue-generating fertility business. It also focuses on the development of class clinical-stage assets in oncology and autoimmune diseases. The company was founded on January 5, 2007 and is headquartered in Sarasota, FL.